Malawi tests new vaccine schedule to better protect children from deadly pneumonia
NCT ID NCT04078997
Summary
This study tested whether changing the timing of pneumococcal vaccine doses works better in Malawi. Researchers compared the standard three-dose schedule (3+0) with a schedule that adds a booster at 9 months (2+1). They measured how well each schedule reduced the bacteria in children's noses, which indicates protection against serious diseases like pneumonia and meningitis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 13-VALENT PNEUMOCOCCAL VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Malawi-Liverpool-Wellcome Research Programme
Blantyre, Chichiri, P.O. Box 30096, Malawi
Conditions
Explore the condition pages connected to this study.